Tommaso Pollini
University of Verona
CancerInternal medicineRadiologySurgeryPathologyOncologyResectionDysplasiaPancreatic cystsIntraductal papillary mucinous neoplasmNeoadjuvant therapyPancreasMalignancyPancreatic cancerPopulationBranch DuctPancreatic ductal adenocarcinomaIncidence (epidemiology)MedicineCohortGastroenterologyMeta-analysis
39Publications
8H-index
169Citations
Publications 39
Newest
#1Giovanni Marchegiani (University of Verona)H-Index: 29
#2Tommaso Pollini (University of Verona)H-Index: 8
Last. Roberto Salvia (University of Verona)H-Index: 52
view all 20 authors...
Importance The progression of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas to malignant disease is still poorly understood. Observational and surgical series have failed to provide comprehensive information. Objective To identify dynamic variables associated with the development of malignant neoplasms by combining pathological features with data from preoperative repeated observations. Design, Setting, and Participants The Crossover Observational Multicentric Study included a...
1 CitationsSource
#1N. Surci (Medical University of Vienna)
Last. Claudio BassiH-Index: 110
view all 12 authors...
Abstract null null Background null Incidental discovery of pancreatic cystic neoplasms (PCLs) is a common and steadily increasing occurrence. The aim of this study was to investigate a cohort of patients presenting with incidentally detected PCLs which were not included in a surveillance protocol, and to compare their risk of malignant evolution with that of systematically surveilled lesions. null null null Materials and methods null A population of PCLs which did not receive surveillance over a...
Source
#1Giovanni Marchegiani (University of Verona)H-Index: 29
#2Stefano Andrianello (University of Verona)H-Index: 16
Last. Roberto Salvia (University of Verona)H-Index: 52
view all 13 authors...
BACKGROUND Despite the low malignant potential of pancreatic mucinous cystic neoplasms (MCNs), surgery is still performed. The aim of this pragmatic study was to assess the outcome of surgery and surveillance for patients presenting with a presumed MCN at the first evaluation. METHODS Data for patients with a presumed MCN observed from 2000 to 2016 at the Verona Pancreas Institute and San Raffaele Hospital were extracted from prospective databases. The endpoints were risk of malignancy at pathol...
Source
#1A. Balduzzi (University of Verona)H-Index: 4
#2Giovanni Marchegiani (University of Verona)H-Index: 29
Last. Roberto Salvia (University of Verona)H-Index: 52
view all 9 authors...
Abstract Background The vast majority of presumed branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) of the pancreas are referred to a surveillance program due to the relatively low risk of malignancy. We aim to evaluate all available data from observational studies focused on the risks of BD-IPMN progression and malignancy to provide vital insights into its management in clinical practice. Methods A comprehensive search was conducted at PubMed, Cochrane, Web of Science and Embase f...
Source
#1N. SimoniH-Index: 5
#1N. SimoniH-Index: 1
Last. Renzo MazzarottoH-Index: 16
view all 15 authors...
Abstract Aims To evaluate the safety and feasibility of stereotactic body radiation therapy (SBRT) with simultaneous integrated boost (SIB) and simultaneous integrated protection (SIP) in borderline resectable and locally advanced pancreatic ductal adenocarcinoma. Materials and methods Patients receiving SBRT following induction chemotherapy from January 2017 to December 2018 were included in this observational analysis. SBRT was delivered in five consecutive daily fractions by administering 30 ...
4 CitationsSource
#2Andrea CaravatiH-Index: 3
Last. Roberto SalviaH-Index: 52
view all 9 authors...
OBJECTIVE Our aim is to provide a real-life picture of serous cystic neoplasms (SCNs) management once a presumptive diagnosis is made. SUMMARY BACKGROUND DATA SCNs of the pancreas are invariably benign entities. While consensus about their management is lacking, surgical resection still plays a role. METHODS Presumed SCNs evaluated from 1990 to 2018 were included. Indications for surgery, predictors of resection, rate and predictors of misdiagnosis in the surgical cohort and time trends of manag...
1 CitationsSource
#1Andrea CaravatiH-Index: 3
#2Stefano AndrianelloH-Index: 16
Last. Roberto SalviaH-Index: 52
view all 9 authors...
Source
#1Ilaria TrestiniH-Index: 7
#2Salvatore PaiellaH-Index: 23
Last. Michele MilellaH-Index: 50
view all 20 authors...
Source
#1Ilaria TrestiniH-Index: 7
#2Salvatore PaiellaH-Index: 23
Last. M. MilellaH-Index: 1
view all 19 authors...
Source
#1Ilaria Trestini (University of Verona)H-Index: 7
#2Salvatore Paiella (University of Verona)H-Index: 23
Last. Michele Milella (University of Verona)H-Index: 50
view all 18 authors...
To evaluate the association between body composition (BC) and systemic inflammatory response (SIR) following neoadjuvant treatment (NAD), and to explore their impact on long-term outcome in pancreatic ductal adenocarcinoma (PDAC) pts. Non-consecutive PDAC pts undergoing surgical exploration after NAD with available CT-scans (both at diagnosis and preoperatively) at two academic medical institutions from 2013 to 2015 were evaluated. BC was assessed by analyzing L3 CT-scan images before and after ...
Source